ARHGDIB and gastric cancer: To determine whether 14-3-3σ expression can alter cellular sensitivity to cisplatin in RhoGDI2-overexpressing gastric cancer cells, we established 14-3-3σ-overexpressing cells in RhoGDI2-overexpressing SNU-484(GDI2-7) cells.